T-PA can only be effectively administered with three hours of a stroke.
<h3>What is T-PA?</h3>
This is referred to as recombinant tissue plasminogen activator and it acts as
a powerful blood thinner which is used in the treatment of stroke
experienced by individuals.
The time the drug is administered is a very important aspect in this form of
treatment. This is because the drug must be effectively administered with
three hours of a stroke. In cases, where this time frame is surpassed, then
other forms of treatment should be given to prevent bleeding in vital organs
of the body such as the brain.
Read more about Tissue plasminogen activator here brainly.com/question/9298370
The pulmonary artery carries deoxygenated blood from the right ventricle to the lungs. The blood here passes through capillaries adjacent to alveoli and becomes oxygenated as part of the process of respiration.
Answer:
Alzheimer's disease is not an inevitable part of aging. Occasional forgetfulness is a normal part of aging, but AD is a serious condition that can cause significant cognitive decline. Symptoms usually start off mild and worsen over time as the disease progresses.
Explanation:
Answer:
Antioxidants are the compounds that inhibit oxidation. Oxidation in the body produces free radicals, which initiates a series of reactions which is harmful the organisms.
Antioxidant are important to include in diet to stop the formation of free radicals. This helps in improving the overall health of the individual and effective at preventing diseases.
Vitamin C and Vitamin E have antioxidant property which stops the cascade of reaction which harms the body. It also reduces the chances of cardiovascular diseases.
Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never been greater. Genomics has the potential to improve the process of vaccine development substantially. Genome sequencing can help to identify genetic patterns related to the virulence of a disease, as well as genetic factors that contribute to immunity or successful vaccine response. All this information could lead to vaccines with better and more specific targets that elicit more successful protective immune responses. Comparing the genome sequences of viruses that cause infection with those that do not may provide additional insights. In turn, genome manipulation can facilitate derivation of attenuated strains or other vehicles for delivery of the desired antigens to stimulate immune response. On the other end of the spectrum, analysis of host diversity can reveal effective immune responses and possibly the genetic basis for inappropriate response. The recent progress in definition of the innate immune system, necessary for acquired response, should facilitate the definition of this host diversity.
